Japan’s health system faces a crisis as the war in the Middle East threatens medical supplies. Doctors warn that shortages of gloves and IV drips could hit within two months, forcing some clinics to refuse treatments. The conflict has stalled oil and naphtha flows from the Gulf, source of critical petrochemicals used in medical goods.

Prime Minister Sanae Takaichi plans to release 50mn gloves from pandemic reserves next month, a move aimed at easing pressure on hospitals that cannot afford soaring prices. The government also unveiled a $10bn aid package to secure crude oil for Southeast Asian manufacturers of medical products, underscoring the link between energy supplies and healthcare costs.

Japanese doctors fear that if shortages persist, clinics will be forced to deny essential treatments like injections and dialysis, potentially driving patients toward larger hospitals. Regulatory limits on hospital pricing mean that rising costs cannot be passed on, squeezing margins and threatening the viability of smaller facilities amid an already strained health budget in 2024.

The crisis spotlights Japan’s vulnerability to global supply shocks, especially as the country relies on petrochemical imports for essential medical goods. With stockpiles of gloves and other consumables already depleting, the government’s intervention may stave off immediate collapse, but long‑term resilience will depend on diversifying sources and tightening supply‑chain transparency for medical providers in 2024.